SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. Valva, M. I. Gismondi, P. C. Casciato, M. Galoppo, C. Lezama, O. Galdame, A. Gadano, M. C. Galoppo, E. Mullen, E. N. De Matteo, M. V. Preciado, Distinctive intrahepatic characteristics of paediatric and adult pathogenesis of chronic hepatitis C infection, Clinical Microbiology and Infection, 2014, 20, 12
  2. 2
    Percy A. Knolle, Robert Thimme, Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection, Gastroenterology, 2014, 146, 5, 1193

    CrossRef

  3. 3
    Michael T. Dill, Zuzanna Makowska, Gaia Trincucci, Andreas J. Gruber, Julia E. Vogt, Magdalena Filipowicz, Diego Calabrese, Ilona Krol, Daryl T. Lau, Luigi Terracciano, Erik van Nimwegen, Volker Roth, Markus H. Heim, Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation, Journal of Clinical Investigation, 2014, 124, 4, 1568

    CrossRef

  4. 4
    Bianca Martin, Nadine Hennecke, Volker Lohmann, Antonin Kayser, Christoph Neumann-Haefelin, George Kukolj, Wulf-Otto Böcher, Robert Thimme, Restoration of HCV-specific CD8+ T cell function by interferon-free therapy, Journal of Hepatology, 2014, 61, 3, 538

    CrossRef

  5. 5
    Jens M. Werner, Elisavet Serti, Xenia Chepa-Lotrea, Jonathan Stoltzfus, Golo Ahlenstiel, Mazen Noureddin, Jordan J. Feld, T. Jake Liang, Yaron Rotman, Barbara Rehermann, Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection, Hepatology, 2014, 60, 4
  6. 6
    Markus H. Heim, 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end, Nature Reviews Immunology, 2013, 13, 7, 535

    CrossRef

  7. 7
    Juan-Ramón Larrubia, Megha-Uttam Lokhande, Elia Moreno-Cubero, Silvia García-Garzón, Joaquín Miquel, Trinidad Parra-Cid, Alejandro González-Praetorious, Cristian Perna, Alicia Lázaro, Eduardo Sanz-de-Villalobos, HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution, Cellular Immunology, 2013, 286, 1-2, 31

    CrossRef

  8. 8
    O. Adeyemo, H. Doi, K. Rajender Reddy, D. E. Kaplan, Impact of oral silymarin on virus- and non-virus-specific T-cell responses in chronic hepatitis C infection, Journal of Viral Hepatitis, 2013, 20, 7
  9. 9
    Patrice Couzigou, Sophie Pérusat, Marc Bourlière, Pascale Trimoulet, Thierry Poynard, Vincent Leroy, Patrick Marcellin, Juliette Foucher, Jean-Pierre Bronowicki, Geneviève Chêne, Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI), Journal of Gastroenterology and Hepatology, 2013, 28, 2
  10. 10
    Yonghong Zhang, Yali Liu, Yan Zhao, Lingxian Shi, Lina Ma, Huiping Yan, Hao Wu, Lai Wei, Tao Dong, Xinyue Chen, Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients, Liver International, 2012, 32, 1
  11. 11
    Tom Pembroke, Ian Rees, Kathleen Gallagher, Emma Jones, Paul Mizen, Timur Navruzov, Andrew Freedman, Ceri Fielding, Ian R. Humphreys, Eddie C. Y. Wang, Awen M. Gallimore, Andrew Godkin, Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+T-cell immunity, European Journal of Immunology, 2012, 42, 9
  12. 12
    B. Soldevila, N. Alonso, M. J. Martínez-Arconada, R. M. Morillas, R. Planas, A. M. Sanmartí, E. M. Martínez-Cáceres, A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment, Journal of Viral Hepatitis, 2011, 18, 6
  13. 13
    J. F. Möller, B. Möller, B. Wiedenmann, T. Berg, E. Schott, CD154, a marker of antigen-specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection, Journal of Viral Hepatitis, 2011, 18, 7
  14. 14
    Bertram Bengsch, Robert Thimme, CD8+T-cell differentiation in chronic HCV infection, Future Virology, 2011, 6, 2, 249

    CrossRef

  15. 15
    Tomohide Tatsumi, Tetsuo Takehara, Takuya Miyagi, Shoichi Nakazuru, Eiji Mita, Tatsuya Kanto, Naoki Hiramatsu, Norio Hayashi, Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-α and ribavirin combination therapy in patients with chronic hepatitis C virus infection, Hepatology Research, 2011, 41, 1
  16. 16
    A. G. Vigani, A. Macedo de Oliveira, R. Tozzo, M. H. P. Pavan, E. S. Gonçales, V. Fais, N. S. Gonçales, F. L. Gonçales, The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2011, 18, 4
  17. 17
    Nathalie Sturm, Marie-Ange Thélu, Xavier Camous, Guéorgui Dimitrov, Muhammad Ramzan, Tania Dufeu-Duchesne, Paula Bonorino, Christiane Guillermet, Elisabeth Brambilla, Philippe Arvers, Martine Pernollet, Vincent Leroy, Jean-Pierre Zarski, Patrice N. Marche, Evelyne Jouvin-Marche, Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis, Journal of Hepatology, 2010, 53, 1, 25

    CrossRef

  18. 18
    Susanne Knapp, Usama Warshow, Doha Hegazy, Louise Brackenbury, I. Neil Guha, Andrew Fowell, Ann-Margaret Little, Graeme J. Alexander, William M.C. Rosenberg, Matthew E. Cramp, Salim I. Khakoo, Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus, Hepatology, 2010, 51, 4
  19. 19
    S. Lee, T. Hammond, M. W. Watson, J. P. Flexman, W. Cheng, S. Fernandez, P. Price, Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-α and ribavirin therapy?, Clinical & Experimental Immunology, 2010, 161, 1
  20. 20
    Giuseppe Castello, Stefania Scala, Giuseppe Palmieri, Steven A. Curley, Francesco Izzo, HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clinical Immunology, 2010, 134, 3, 237

    CrossRef

  21. 21
    D. Wodarz, Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responses, Proceedings of the Royal Society B: Biological Sciences, 2010, 277, 1689, 1875

    CrossRef

  22. 22
    Joop E. Arends, Mark A.A. Claassen, Charlotte H.S.B. van den Berg, Nening M. Nanlohy, Karel J. van Erpecum, Bert C. Baak, Andy I.M. Hoepelman, Andre Boonstra, Debbie van Baarle, T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients, Antiviral Research, 2010, 87, 3, 353

    CrossRef

  23. 23
    V. M. Fleming, G. Harcourt, E. Barnes, P. Klenerman, Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection, Journal of General Virology, 2010, 91, 6, 1396

    CrossRef

  24. 24
    Mareike Mueller, Hans Christian Spangenberg, Nadine Kersting, Tayibe Altay, Hubert E. Blum, Paul Klenerman, Robert Thimme, Nasser Semmo, Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154, Journal of Hepatology, 2010, 52, 6, 800

    CrossRef

  25. 25
    Xinjian Zhang, Jun Dou, Markus W. Germann, Characterization of the cellular immune response in hepatitis C virus infection, Medicinal Research Reviews, 2009, 29, 6
  26. 26
    C.S. Klade, A. Kubitschke, R.E. Stauber, M.F. Meyer, S. Zinke, J. Wiegand, W. Zauner, N. Aslan, M. Lehmann, M. Cornberg, M.P. Manns, P. Reisner, H. Wedemeyer, Hepatitis C virus-specific T cell responses against conserved regions in recovered patients, Vaccine, 2009, 27, 23, 3099

    CrossRef

  27. 27
    Yutaka Kishida, Yoshimichi Haruna, Masahumi Naitoh, Kazuhiro Katayama, Toru Kashiwagi, Multiple Cytokine Profiling of the Therapeutic Responses to Ribavirin and Pegylated Interferon-α2b Using an “Induction” Approach With Natural Interferon-β in Difficult-to-Treat Chronic Hepatitis C, Journal of Interferon & Cytokine Research, 2009, 29, 6, 353

    CrossRef

  28. 28
    J. E. Arends, J. Cohen Stuart, L. C. Baak, M. E. Van Der Ende, K. J. Van Erpecum, C. P. M. Simons, G. J. Boland, D. Van Baarle, A. I. M. Hoepelman, Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy, Journal of Viral Hepatitis, 2009, 16, 12
  29. 29
    Heiner Wedemeyer, Elisabeth Schuller, Verena Schlaphoff, Rudolf E. Stauber, Johannes Wiegand, Ingolf Schiefke, Christa Firbas, Bernd Jilma, Mark Thursz, Stefan Zeuzem, Wolf P. Hofmann, Holger Hinrichsen, Erich Tauber, Michael P. Manns, Christoph S. Klade, Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C, Vaccine, 2009, 27, 37, 5142

    CrossRef

  30. 30
    Tania Mara Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O'Brien, Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial, Hepatology, 2009, 49, 6
  31. 31
    M. Danta, N. Semmo, P. Fabris, D. Brown, O. G. Pybus, C. A. Sabin, S. Bhagani, V. C. Emery, G. M. Dusheiko, P. Klenerman, Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection, The Journal of Infectious Diseases, 2008, 197, 11, 1558

    CrossRef

  32. 32
    David E. Kaplan, Fusao Ikeda, Yun Li, Nobuhiro Nakamoto, Sutharsan Ganesan, Mary E. Valiga, Frederick A. Nunes, K. Rajender Reddy, Kyong-Mi Chang, Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis, Journal of Hepatology, 2008, 48, 6, 903

    CrossRef

  33. 33
    James R. Burton, Jared Klarquist, KyungAh Im, Sue Smyk-Pearson, Lucy Golden-Mason, Nicole Castelblanco, Norah Terrault, Hugo R. Rosen, Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy, Journal of Hepatology, 2008, 49, 3, 329

    CrossRef

  34. 34
    Satoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, Yutaka Honda, Masaaki Takamura, Satoshi Sugahara, Toru Ishikawa, Shogo Ohkoshi, Yoshinobu Sato, Yutaka Aoyagi, Sustained response to interferon-α plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells, Hepatology Research, 2008, 38, 7
  35. 35
    Carlo Ferrari, Therapeutic Vaccination for Hepatitis C: Can Protective T-Cell Responses Be Restored After Prolonged Antigen Exposure?, Gastroenterology, 2008, 134, 5, 1601

    CrossRef

  36. 36
    Christoph S. Klade, Heiner Wedemeyer, Thomas Berg, Holger Hinrichsen, Grazyna Cholewinska, Stefan Zeuzem, Hubert Blum, Michael Buschle, Sandra Jelovcan, Vera Buerger, Erich Tauber, Juergen Frisch, Michael P. Manns, Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41, Gastroenterology, 2008, 134, 5, 1385

    CrossRef

  37. 37
    Pin-Nan Cheng, Ya-Ling Wei, Ting-Tsung Chang, Jiann-Shiuh Chen, Kung-Chia Young, Therapy with interferon-α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells, Journal of Medical Virology, 2008, 80, 6
  38. 38
    N. Semmo, G. Krashias, C. Willberg, P. Klenerman, Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection, Journal of Viral Hepatitis, 2007, 14, 7
  39. 39
    Vinodh Pillai, William M. Lee, Dwain L. Thiele, Nitin J. Karandikar, Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses, Journal of Viral Hepatitis, 2007, 14, 5
  40. 40
    Lynn Averill, William M. Lee, Nitin J. Karandikar, Differential dysfunction in dendritic cell subsets during chronic HCV infection, Clinical Immunology, 2007, 123, 1, 40

    CrossRef

  41. 41
    Lynn B. Dustin, Charles M. Rice, Flying Under the Radar: The Immunobiology of Hepatitis C, Annual Review of Immunology, 2007, 25, 1, 71

    CrossRef

  42. 42
    Massimo Pilli, Alessandro Zerbini, Amalia Penna, Alessandra Orlandini, Esther Lukasiewicz, Jean–Michel Pawlotsky, Stefan Zeuzem, Solko W. Schalm, Michael von Wagner, Georgios Germanidis, Yoav Lurie, Juan I. Esteban, Bart L. Haagmans, Christophe Hezode, Martin Lagging, Francesco Negro, Yonit Homburger, Avidan U. Neumann, Carlo Ferrari, Gabriele Missale, HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project), Gastroenterology, 2007, 133, 4, 1132

    CrossRef

  43. 43
    H. Miyatake, T. Kanto, M. Inoue, M. Sakakibara, A. Kaimori, T. Yakushijin, I. Itose, M. Miyazaki, N. Kuzushita, N. Hiramatsu, T. Takehara, A. Kasahara, N. Hayashi, Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2007, 14, 6
  44. 44
    Scott M. Ward, Bridget C. Fox, Philip J. Brown, Joy Worthington, Stephen B. Fox, Roger W. Chapman, Kenneth A. Fleming, Alison H. Banham, Paul Klenerman, Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection, Journal of Hepatology, 2007, 47, 3, 316

    CrossRef

  45. 45
    Norma Ibón Rallón, Vicente Soriano, José Miguel Benito, Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C, Medicina Clínica, 2007, 129, 12, 469

    CrossRef

  46. 46
    J. Cao, X.L. Liao, S.M. Wu, P. Zhao, L.J. Zhao, W.B. Wu, Z.T. Qi, Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81, Journal of Microbiological Methods, 2007, 68, 3, 601

    CrossRef

  47. 47
    Hugo R. Rosen, Scott J. Weston, KyungAh Im, Huiying Yang, James R. Burton, Henry Erlich, Jared Klarquist, Steven H. Belle, Selective decrease in hepatitis C virus–specific immunity among African Americans and outcome of antiviral therapy, Hepatology, 2007, 46, 2
  48. 48
    Simon M Rushbrook, Matthew Hoare, Graeme JM Alexander, T-regulatory lymphocytes and chronic viral hepatitis, Expert Opinion on Biological Therapy, 2007, 7, 11, 1689

    CrossRef

  49. 49
    David E. Kaplan, Kyong-Mi Chang, Current status of vaccine therapy for hepatitis c infection, Current Hepatitis Reports, 2006, 5, 2, 68

    CrossRef

  50. 50
    Dominik Wodarz, Ecological and evolutionary principles in immunology, Ecology Letters, 2006, 9, 6
  51. 51
    Tony Wang, Lawrence M. Blatt, Scott D. Seiwert, Immunomodulatory Activities of IFN-γ1b in Combination with Type I IFN: Implications for the Use of IFN-γ1b in the Treatment of Chronic HCV Infections, Journal of Interferon & Cytokine Research, 2006, 26, 7, 473

    CrossRef

  52. 52
    Tatsuya Kanto, Norio Hayashi, Immunopathogenesis of Hepatitis C Virus Infection: Multifaceted Strategies Subverting Innate and Adaptive Immunity, Internal Medicine, 2006, 45, 4, 183

    CrossRef

  53. 53
    N. Bonilla, N. Barget, M. Andrieu, D. Roulot, P. Letoumelin, V. Grando, J. C. Trinchet, N. Ganne-Carrié, M. Beaugrand, P. Deny, J. Choppin, J. Guillet, M. Ziol, Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis – ANRS HC EP07 study, Journal of Viral Hepatitis, 2006, 13, 7
  54. 54
    Camilla S Graham, Annalee Wells, Tun Liu, Kenneth E Sherman, Marion Peters, Raymond T Chung, Atul K Bhan, Janet Andersen, Margaret James Koziel, Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection, AIDS, 2006, 20, 3, 345

    CrossRef

  55. 55
    M. TRAPERO-MARUGÁN, L. GARCÍA-BUEY, C. MUÑOZ, N. E. QUINTANA, J. A. MORENO-MONTEAGUDO, M. J. BORQUE, M. J. FERNÁNDEZ, F. R. SALVANÉS, J. MEDINA, R. MORENO-OTERO, Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response, Alimentary Pharmacology & Therapeutics, 2006, 24, 1
  56. 56
    K. Kobayashi, M. Ishii, M. Shiina, Y. Ueno, Y. Kondo, A. Kanno, Y. Miyazaki, T. Yamamoto, T. Kobayashi, H. Niitsuma, Y. Kikumoto, H. Takizawa, T. Shimosegawa, Interferon-γ is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss, Clinical & Experimental Immunology, 2005, 141, 1
  57. 57
    Nasser Semmo, Cheryl L. Day, Scott M. Ward, Michaela Lucas, Gillian Harcourt, Andrew Loughry, Paul Klenerman, Preferential loss of IL-2–secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005, 41, 5
  58. 58
    C. Neumann-Haefelin, H.E. Blum, F.V. Chisari, R. Thimme, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005, 32, 2, 75

    CrossRef

  59. 59
    Nasser Semmo, Eleanor Barnes, Craig Taylor, John Kurtz, Gillian Harcourt, Neil Smith, Paul Klenerman, T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors, The Lancet, 2005, 365, 9456, 327

    CrossRef

  60. 60
    David E. Kaplan, Kazushi Sugimoto, Fusao Ikeda, Jason Stadanlick, Mary Valiga, Kirti Shetty, K. Rajender Reddy, Kyong-Mi Chang, T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C, Hepatology, 2005, 41, 6
  61. 61
    Donald D. Anthony, Donald E. Hricik, Peter S. Heeger, Measuring Immunity, 2005,

    CrossRef

  62. 62
    Tatsuya Kanto, Measuring Immunity, 2005,

    CrossRef

  63. 63
    Armin Luik, Susanne Knapp, Mark Thursz, Howard C. Thomas, Jörg F. Schlaak, Autoregulatory Role of Interleukin-10 in Hepatitis C Patients Treated with IFN-α, Journal of Interferon & Cytokine Research, 2004, 24, 10, 585

    CrossRef

  64. 64
    Paul Klenerman, Nasser Semmo, Scott Ward, Cellular immune responses against HCV: T cells take a diversion in the liver, Hepatology, 2004, 40, 6
  65. 65
    Johannes Wiegand, Elmar Jäckel, Markus Cornberg, Holger Hinrichsen, Manfred Dietrich, Julian Kroeger, Wolfgang P. Fritsch, Anne Kubitschke, Nuray Aslan, Hans L. Tillmann, Michael Peter Manns, Heiner Wedemeyer, Long-term follow-up after successful interferon therapy of acute hepatitis C, Hepatology, 2004, 40, 1
  66. 66
    Teresa Casanovas-Taltavull, M. Guadalupe Ercilla, Cecilia P. Gonzalez, Elias Gil, Odette Viñas, Concha Cañas, Aurora Casanova, Juan Figueras, Teresa Serrano, Luis A. Casais, Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance, Liver Transplantation, 2004, 10, 5
  67. 67
    G. C. Harcourt, M. Lucas, I. Sheridan, E. Barnes, R. Phillips, P. Klenerman, Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes, Journal of Viral Hepatitis, 2004, 11, 4
  68. 68
    G. Missale, E. Cariani, C. Ferrari, Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?, Digestive and Liver Disease, 2004, 36, 11, 703

    CrossRef

  69. 69
    Andrew H. Talal, M. Tarek Shata, Marianthi Markatou, Gary Dorante, Amy Chadburn, Robert Koch, Avidan U. Neumann, Ruy M. Ribeiro, Alan S. Perelson, Virus Dynamics and Immune Responses During Treatment in Patients Coinfected With Hepatitis C and HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004, 35, 2, 103

    CrossRef

  70. 70
    Miguel A. Rico, Sara Ruiz, Dolores Subirá, Guillermina Barril, Secundino Cigarrán, Susana Castañón, Juan A. Quiroga, Rafael Selgas, Vicente Carreño, Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection, Journal of Medical Virology, 2004, 72, 1
  71. 71
    N. L. Komarova, E. Barnes, P. Klenerman, D. Wodarz, Boosting immunity by antiviral drug therapy: A simple relationship among timing, efficacy, and success, Proceedings of the National Academy of Sciences, 2003, 100, 4, 1855

    CrossRef

  72. 72
    Jayaprakash Sreenarasimhaiah, Andrés Jaramillo, Jeffrey Crippin, Mauricio Lisker-Melman, William C Chapman, T Mohanakumar, Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infection, Human Immunology, 2003, 64, 5, 497

    CrossRef

  73. 73
    G. C. HARCOURT, M. LUCAS, A. J. GODKIN, M. KANTZANOU, R. E. PHILLIPS, P. KLENERMAN, Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection, Clinical & Experimental Immunology, 2003, 131, 1
  74. 74
    Chihiro Morishima, Luwy Musey, Marnie Elizaga, Kersten Gaba, Megan Allison, Robert L Carithers, David R Gretch, M.Juliana McElrath, Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy, Clinical Immunology, 2003, 108, 3, 211

    CrossRef

  75. 75
    K. Murata, M. Lechmann, M. Qiao, T. Gunji, H. J. Alter, T. J. Liang, Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection, Proceedings of the National Academy of Sciences, 2003, 100, 11, 6753

    CrossRef